|
|||||
|
|
Point sur les cancers du poumon en 2010 |
|
| Institution: | 1. 251 Airforce General Hospital, Department of Medical Oncology, Athens, Greece;2. “Alexandra” University Hospital, Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece;3. Health Data Specialists Office, Athens, Greece |
| Abstract: | The year 2009 has lead to new data clearly impacting therapeutic management strategies in NSCLC. Personalized medicine is becoming a reality for patients with EGFR mutation as well as for the recruitment of patients in certain clinical trials (EML4-ALK translocation, KRAS mutation…). Maintenance trials are based on questionable statistical designs but this approach may have an interest in certain subset of patients. Little improvements are being achieved in SCLC and locally advanced NSCLC. |
| Keywords: | cancer du poumon thérapie ciblée chimiothérapie maintenance EGFR lung cancer targeted therapies chemotherapy maintenance EGFR |
| 本文献已被 ScienceDirect 等数据库收录！ | |